Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD

Ekaterina Kochetova (Petrozavodsk, Republic of Karelia, Russian Federation), Ekaterina Kochetova

Source: International Congress 2015 – COPD: notable points
Session: COPD: notable points
Session type: Poster Discussion
Number: 4798
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ekaterina Kochetova (Petrozavodsk, Republic of Karelia, Russian Federation), Ekaterina Kochetova. Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 4798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014

Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015


FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


The influence of O2 on exercise capacity (6-minute-walking-distance, 6MWD) in COPD
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011

Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Heart rate recovery after 6-min walk test predicts acute exacerbation in COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015


To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

CAT in COPD phenotypes (POPE study)
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015